NCT06275854

Brief Summary

The goal of this observational research registry is to learn about health, wellbeing, and needs of survivors of young adult cancer (diagnosed between the ages of 18 and 39). The main question\[s\] it aims to understand are:

  • What are the levels of depression, anxiety, social support, and financial distress
  • Determine effectiveness of YASU programming by measuring changes over time With this registry, the investigators also plan to identify survivors who may be eligible for participation in future research studies pertaining to young adult cancer. Participants will be asked to complete electronic surveys every 6 to 12 months during participation in the registry.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
192

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 22, 2024

Completed
1 month until next milestone

First Posted

Study publicly available on registry

February 23, 2024

Completed
12 months until next milestone

Study Start

First participant enrolled

February 3, 2025

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2025

Completed
Last Updated

October 14, 2025

Status Verified

October 1, 2025

Enrollment Period

8 months

First QC Date

January 22, 2024

Last Update Submit

October 8, 2025

Conditions

Keywords

young adult cancer

Outcome Measures

Primary Outcomes (5)

  • Anxiety

    General Anxiety Disorder-7 (GAD-7). Scores range from 0-21 with higher scores indicating higher levels of anxiety.

    enrollment in registry, 6 months later, yearly until death

  • Depressive symptoms

    Patient Health Questionnaire- 9 (PHQ-9) Scores range from 0-27, with higher scores indicating more depressive symptoms.

    enrollment in registry, 6 months later, yearly until death

  • Social Support

    MOS Social Support Survey Instrument The survey consists of four separate social support subscales and an overall functional social support index. A higher score for an individual scale or for the overall support index indicates more support. MOS Social Support Survey Instrument Measure of Social Support Survey Instrument

    enrollment in registry, 6 months later, yearly until death

  • Financial Toxicity

    COST: A FACIT Measure of Financial Toxicity (COST - FACIT (Ver 2)) Scores range from 0-44. The higher the score, the better the Financial Well-Being

    enrollment in registry, 6 months later, yearly until death

  • Needs Assessment

    AYA Psycho-Oncology Screening Tool (AYA-POST) There is no scoring required for this tool.

    enrollment in registry

Secondary Outcomes (1)

  • Name, address, email, phone number

    enrollment in registry

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Any young adult diagnosed with cancer between the ages of 18 and 39 willing to register on the YASU website and consents to participation in the research registry.

You may qualify if:

  • Cancer diagnosis received between the ages of 18 and 39.
  • Able to speak and read English

You may not qualify if:

  • Inability to provide consent (such as neurological illness or mental incapacity)
  • Has not registered as a member of YASU

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Young Adult Survivors United

Wexford, Pennsylvania, 15090, United States

Location

MeSH Terms

Conditions

NeoplasmsLeukemiaSarcomaNeoplasms, Germ Cell and EmbryonalLymphomaColorectal NeoplasmsMelanomaBreast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by Histologic TypeHematologic DiseasesHemic and Lymphatic DiseasesNeoplasms, Connective and Soft TissueLymphoproliferative DisordersLymphatic DiseasesImmunoproliferative DisordersImmune System DiseasesIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal DiseasesNeuroendocrine TumorsNeuroectodermal TumorsNeoplasms, Nerve TissueNevi and MelanomasSkin NeoplasmsSkin DiseasesSkin and Connective Tissue DiseasesBreast Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
10 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 22, 2024

First Posted

February 23, 2024

Study Start

February 3, 2025

Primary Completion

September 30, 2025

Study Completion

September 30, 2025

Last Updated

October 14, 2025

Record last verified: 2025-10

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL, SAP
Time Frame
Starting once enrollment has been open for 6 months.
Access Criteria
In order to be granted access to our dataset, the outside researcher would need to secure IRB approval for their proposed study and then would sign a YASU-provided confidentiality agreement. Datasets shared with researchers outside of YASU will not include identifiers. Future research collaborators outside of YASU may use the registry to contact participants for other studies and may have access to screen for candidates. Outside researchers who wish to use contacts from the YASU research registry in recruitment for their study will be required to secure IRB approval for their proposed study and to complete the YASU-provided confidentiality agreement prior to any possible participant contact information being shared. Once IRB-approval has been received and the agreement is completed, the PI (and/or YASU executive director) may grant the requestor access to the requested information.

Locations